Moderna swings to profit as momentum for cancer vaccine builds - Financial Times
Source:Financial Times
Biotech company remains strongest performer in S&P 500 over past year
Related Articles
White House’s ‘lack of organization’ has AI lobbyists fretting - Politico
The Trump administration has sent mixed signals about how tough it intends to be in vetting powerful …
Private credit group Ares draws nearly $20bn from investors - Financial Times
Real estate and infrastructure commitments help offset weakness in group’s core business
Moderna’s president weighs in on FDA’s decision not to review its flu vaccine - statnews.com
In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the …
Coinbase says deal reached on Clarity Act stablecoin yield, clearing path to long-stalled Senate markup - The Block
Coinbase CEO Brian Armstrong urged the Senate Banking Committee to “mark it up” as a …